MS drug during pregnancy: what happens to Baby's immunity?
NCT ID NCT07149662
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 28 times
Summary
This study follows 111 children born to women with multiple sclerosis who received rituximab (or similar drugs) before or during pregnancy. Researchers will check the babies' B-cell levels, infection rates, and vaccine responses in their first year. The goal is to understand if the drug affects the infant's immune system and how long it stays in the mother's body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Academic specialist center, Center for Neurology
Stockholm, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.